276 related articles for article (PubMed ID: 23634895)
1. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
Joshi YB; Chu J; Praticò D
Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
[TBL] [Abstract][Full Text] [Related]
2. Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in a mouse model of Alzheimer's disease.
Joshi YB; Giannopoulos PF; Chu J; Sperow M; Kirby LG; Abood ME; Praticò D
Hum Mol Genet; 2014 Dec; 23(25):6894-902. PubMed ID: 25122659
[TBL] [Abstract][Full Text] [Related]
3. 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease.
Chu J; Giannopoulos PF; Ceballos-Diaz C; Golde TE; Praticò D
Ann Neurol; 2012 Sep; 72(3):442-54. PubMed ID: 23034916
[TBL] [Abstract][Full Text] [Related]
4. Modulation of lipopolysaccharide-induced memory insult, γ-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase.
Joshi YB; Giannopoulos PF; Chu J; Praticò D
Neurobiol Aging; 2014 May; 35(5):1024-31. PubMed ID: 24332986
[TBL] [Abstract][Full Text] [Related]
5. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Li JG; Praticò D
PLoS One; 2013; 8(8):e70991. PubMed ID: 23951061
[TBL] [Abstract][Full Text] [Related]
6. The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: in vivo and in vitro evidence.
Chu J; Li JG; Ceballos-Diaz C; Golde T; Praticò D
Biol Psychiatry; 2013 Sep; 74(5):321-8. PubMed ID: 23352590
[TBL] [Abstract][Full Text] [Related]
7. Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice.
Di Meco A; Lauretti E; Vagnozzi AN; Praticò D
Neurobiol Aging; 2014 Nov; 35(11):2458-2464. PubMed ID: 24973121
[TBL] [Abstract][Full Text] [Related]
8. 5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5.
Chu J; Praticò D
Neurobiol Aging; 2013 Jun; 34(6):1549-54. PubMed ID: 23332172
[TBL] [Abstract][Full Text] [Related]
9. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease.
Giannopoulos PF; Chu J; Joshi YB; Sperow M; Li JG; Kirby LG; Praticò D
Mol Psychiatry; 2014 Apr; 19(4):511-8. PubMed ID: 23478745
[TBL] [Abstract][Full Text] [Related]
10. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
[TBL] [Abstract][Full Text] [Related]
11. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation.
Wang WZ; Li MW; Chen Y; Liu LY; Xu Y; Xia ZH; Yu Y; Wang XD; Chen W; Zhang F; Xu XY; Gao YF; Zhang JG; Qin SC; Wang H
J Alzheimers Dis; 2021; 82(4):1635-1649. PubMed ID: 34219730
[TBL] [Abstract][Full Text] [Related]
12. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
13. Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice.
Vagnozzi AN; Giannopoulos PF; Praticò D
Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29106033
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
15. Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease.
Joshi YB; Chu J; Praticò D
J Alzheimers Dis; 2012; 31(1):167-76. PubMed ID: 22531419
[TBL] [Abstract][Full Text] [Related]
16. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
17. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
18. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
Vagnozzi AN; Giannopoulos PF; Praticò D
Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
[TBL] [Abstract][Full Text] [Related]
20. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
